Technology | 2010.08.26
Spectral Molecular Imaging, Inc. Announces Accelerated Timeline for its Early Melanoma Detection Product SkinSpect™
BEVERLY HILLS, Calif.--(BUSINESS WIRE)--Cascade Technologies, Inc. (OTCBB: CSDT) announced today that its wholly-owned subsidiary Spectral Molecular Imaging, Inc. (SMI) will complete development of its new product SkinSpect™, aimed at early detection of melanoma by hyperspectral imaging, in mid-September 2010, significantly ahead of schedule. The device incorporates new advances in component technologies (optics, cameras, displays, embedded computers and software), as well as experience derived
For more information, please visit
http://www.businesswire.com/news/home/20100826005910/en
